{"rows":[{"id":5807,"title":"How should psychotherapy proceed when adjoined with psychedelics?","authors":"Marc J. Weintraub, David J. Miklowitz","journal":"World Psychiatry","publication_date":"2024-01-12","publication_year":2024,"doi":"10.1002/wps.21170","pubmed_id":"38214635","openalex_id":"https://openalex.org/W4390795044","source_url":"https://doi.org/10.1002/wps.21170","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Mechanism of Action,Consciousness,Emotional Processing,Clinical Trial,Healthcare Workers,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-09 08:25:31","last_checked":"2026-08-09 08:25:31","bibtex":null,"source_record_id":"PMID:38214635","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1002/wps.21170","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:38214635","source_url":"https://doi.org/10.1002/wps.21170","doi":"10.1002/wps.21170","pmid":"38214635","publication_date":"2024-01-12","importer_version":"2.1.3","text_redistributed":false}},{"id":5157,"title":"Serotonin, psychedelics and psychiatry","authors":"Robin Carhart-Harris","journal":"World Psychiatry","publication_date":"2018-09-07","publication_year":2018,"doi":"10.1002/wps.20555","pubmed_id":"30192100","openalex_id":"https://openalex.org/W2891343109","source_url":"https://doi.org/10.1002/wps.20555","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Randomized Controlled Trial,Safety","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:01","last_checked":"2026-08-09 08:25:50","bibtex":null,"source_record_id":"PMID:30192100","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1002/wps.20555","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:30192100","source_url":"https://doi.org/10.1002/wps.20555","doi":"10.1002/wps.20555","pmid":"30192100","publication_date":"2018-09-07","importer_version":"2.1.3","text_redistributed":false}},{"id":5091,"title":"The need for publicly funded research on therapeutic use of psychedelic drugs","authors":"Wayne Hall","journal":"World Psychiatry","publication_date":"2021-05-18","publication_year":2021,"doi":"10.1002/wps.20847","pubmed_id":"34002493","openalex_id":"https://openalex.org/W3162774823","source_url":"https://doi.org/10.1002/wps.20847","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Headache / Migraine,Pharmacology,Mechanism of Action,Receptor Pharmacology,Wellbeing,Emotional Processing,Spirituality,Clinical Trial,Randomized Controlled Trial,Observational Study,Treatment-Resistant Depression,Safety","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:59","last_checked":"2026-08-09 08:25:45","bibtex":null,"source_record_id":"PMID:34002493","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1002/wps.20847","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:34002493","source_url":"https://doi.org/10.1002/wps.20847","doi":"10.1002/wps.20847","pmid":"34002493","publication_date":"2021-05-18","importer_version":"2.1.3","text_redistributed":false}},{"id":4769,"title":"The psychedelic experience and treatment-resistant depression","authors":"Guy M. Goodwin","journal":"World Psychiatry","publication_date":"2023-09-15","publication_year":2023,"doi":"10.1002/wps.21140","pubmed_id":"37713542","openalex_id":"https://openalex.org/W4386765441","source_url":"http://dx.doi.org/10.1002/wps.21140","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Personality Change,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Healthy Volunteers,Treatment-Resistant Depression,Safety,Adverse Events,Drug Interactions","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:45","last_checked":"2026-08-09 08:25:34","bibtex":null,"source_record_id":"PMID:37713542","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"http://dx.doi.org/10.1002/wps.21140","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:37713542","source_url":"http://dx.doi.org/10.1002/wps.21140","doi":"10.1002/wps.21140","pmid":"37713542","publication_date":"2023-09-15","importer_version":"2.1.3","text_redistributed":false}},{"id":4294,"title":"Trauma under psychedelics: how psychoactive substances impact trauma processing","authors":"Ophir Netzer, Noa Magal, Yonatan Stern, Tzuk Polinsky, Raz Gross, Roee Admon, Roy Salomon","journal":"World Psychiatry","publication_date":"2025-09-15","publication_year":2025,"doi":"10.1002/wps.21363","pubmed_id":"40948086","openalex_id":"https://openalex.org/W4414167960","source_url":"https://doi.org/10.1002/wps.21363","substance_tags":"psilocybin","topic_tags":"PTSD,Addiction,End-of-Life Distress,Receptor Pharmacology,Observational Study,Safety,Drug Interactions","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:39","last_checked":"2026-08-09 08:25:17","bibtex":null,"source_record_id":"PMID:40948086","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1002/wps.21363","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:40948086","source_url":"https://doi.org/10.1002/wps.21363","doi":"10.1002/wps.21363","pmid":"40948086","publication_date":"2025-09-15","importer_version":"2.1.3","text_redistributed":false}}],"total":5,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"World Psychiatry","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}